Colonisation Efficacy of a Probiotic Chewing Gum. - Trial NCT05624177
Access comprehensive clinical trial information for NCT05624177 through Pure Global AI's free database. This phase not specified trial is sponsored by BLIS Technologies Limited and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Streptococcus salivarius M18 probiotic 1 billion colony forming units chewing gum (chew 5 minutes)
Interventional
dietary supplement
Sponsor & Location
BLIS Technologies Limited
Timeline & Enrollment
N/A
Dec 01, 2022
Mar 01, 2023
Primary Outcome
Change in Microbial colonization from baseline (Day 0) to 1 hour.,Change in Microbial colonization from baseline (Day 0) to 8 hours.,Change in Microbial colonization from baseline (Day 0) to 8 hours post last dose.,Change in Microbial colonization from baseline (Day 0) to 48 hours post last dose.
Summary
To evaluate the colonization efficacy (the ability of a probiotic bacteria to remain in the
 mouth) delivered in a chewing gum format. The chewing gum contains Streptococcus salivarius
 probiotic and the study is to be done in health adults.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05624177
Non-Device Trial